Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saeed Bohlega

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Current Medical Research and Opinion|October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosisDouglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Human Genomics|November 8, 2017
Identification of a novel genetic locus underlying tremor and dystoniaDorota Monies, Hussam Abou Al-Shaar, Ewa A Goljan, et al.
Multiple Sclerosis and Related Disorders|April 15, 2021
Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi ArabiaMohammed Al Jumah, Ahmad Abulaban, Hani Aggad, et al.
Journal of Clinical Lipidology|June 6, 2025
Clinical variability in cerebrotendinous xanthomatosis (CTX): Insights from 16 cases across Gulf Cooperation Council's (GCC's) high consanguineous populationMohammed A Almuqbil, Mashael M ALQuaimi, Al Qasim Al-Bahlani, et al.
Multiple Sclerosis International|March 22, 2021
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon <i>β</i>-1aMohammed Al Jumah, Suleiman Kojan, Raed Alroughani, et al.
Neurology and Therapy|April 17, 2020
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative ReviewIsa Ahmed AlSharoqi, Mohamed Aljumah, Saeed Bohlega, et al.
Human Molecular Genetics|May 23, 2002
Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotypeSubramaniam Ganesh, Antonio V Delgado-Escueta, Toshimitsu Suzuki, et al.
Multiple Sclerosis International|January 13, 2017
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksRaed Alroughani, Ayse Altintas, Mohammed Al Jumah, et al.
Human Genomics|September 28, 2016
A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathiesDorota Monies, Hindi N Alhindi, Mohamed A Almuhaizea, et al.
BMC Neurology|October 17, 2015
Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group, Fatma Al Jasmi, Mohammed Al Jumah, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Current Medical Research and Opinion|October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosisDouglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Human Genomics|November 8, 2017
Identification of a novel genetic locus underlying tremor and dystoniaDorota Monies, Hussam Abou Al-Shaar, Ewa A Goljan, et al.
Multiple Sclerosis and Related Disorders|April 15, 2021
Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi ArabiaMohammed Al Jumah, Ahmad Abulaban, Hani Aggad, et al.
Journal of Clinical Lipidology|June 6, 2025
Clinical variability in cerebrotendinous xanthomatosis (CTX): Insights from 16 cases across Gulf Cooperation Council's (GCC's) high consanguineous populationMohammed A Almuqbil, Mashael M ALQuaimi, Al Qasim Al-Bahlani, et al.
Multiple Sclerosis International|March 22, 2021
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon <i>β</i>-1aMohammed Al Jumah, Suleiman Kojan, Raed Alroughani, et al.
Neurology and Therapy|April 17, 2020
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative ReviewIsa Ahmed AlSharoqi, Mohamed Aljumah, Saeed Bohlega, et al.
Human Molecular Genetics|May 23, 2002
Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotypeSubramaniam Ganesh, Antonio V Delgado-Escueta, Toshimitsu Suzuki, et al.
Multiple Sclerosis International|January 13, 2017
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksRaed Alroughani, Ayse Altintas, Mohammed Al Jumah, et al.
Human Genomics|September 28, 2016
A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathiesDorota Monies, Hindi N Alhindi, Mohamed A Almuhaizea, et al.
BMC Neurology|October 17, 2015
Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group, Fatma Al Jasmi, Mohammed Al Jumah, et al.
Pageof 7